Skip to main content

Companies researching Keytruda (pembrolizumab)

Keytruda (pembrolizumab) is a humanized monoclonal antibody used in cancer immunotherapy to treat melanoma, lung, head‑and‑neck, Hodgkin lymphoma, stomach, cervical and certain breast cancers, administered via intravenous infusion.

List of companies that research Keytruda (pembrolizumab)

This is sourced from job postings — companies only hire for what they actively use or plan to adopt · how we source this →

CompanyCountryIndustryEmployeesRevenueTechnologies

United States

Biotechnology Research

394

Keytruda (pembrolizumab)

United States

Biotechnology Research

324

Keytruda (pembrolizumab)

Canada

Financial Services

1.3k

Keytruda (pembrolizumab)

United States

Pharmaceutical Manufacturing

3.6k

$15M

Keytruda (pembrolizumab)

Italy

Hospitals and Health Care

6.1k

Keytruda (pembrolizumab)

United States

Business Consulting and Services

97

$18M

Keytruda (pembrolizumab)

United States

Hospitals and Health Care

21k

$5.5B

Keytruda (pembrolizumab)

United States

Hospitals and Health Care

1k

$4.2M

Keytruda (pembrolizumab)

Netherlands

Hospitals and Health Care

10k

$3.8M

Keytruda (pembrolizumab)

United States

Medical Practices

277

$17M

Keytruda (pembrolizumab)

Showing top companies out of 48 that research Keytruda (pembrolizumab). Get the full list on TheirStack.

Frequently asked questions